OSX secures Latin America deal for craniofacial distribution
Filed with ASX · · 5 pages · English
• Osteopore strengthens its distribution line-up for Latin America through an exclusive partnership with Medprin Biotech GmbH, a fully-owned subsidiary of Medprin Regenerative Medical Technologies Co., Ltd, a listed company on the ChiNext market of the Shenzhen Stock Exchange (301033.SZ). • The business will focus on the craniofacial reconstruction market in Latin America – the most developed prod
Story so far
Earlier from Osteopore
- Osteopore Secures Latin America Deal For Craniofacial Distribution
- Further Drawdown of T1 of the Redeemable Convertible Notes
- Activities Report December 2025 and Appendix 4C
- Clarification - agreement for orthopaedic products in HK
- OSX strikes agreement for orthopaedic products in Hong Kong
Later from Osteopore
- Drawdown of Tranche 2 of the Redeemable Convertible Notes
- Appendix 4E Preliminary Final Report
- OSX secures distribution for autologous dentin bone graft
- OSX signs agreement for injectable regenerative bone filler
- Clarification - agreement for injectable regen bone filler
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore